EUVIMEDEUVIMED entdecken
BeobachtungsstudieMultizentrische Studie

Efficacy of De-Escalation to Cefmetazole in Patients with Bacteremic Urinary Tract Infections Caused by Extended-Spectrum β-Lactamase-Producing Escherichia coli

Takaya Namiki, Yuta Yokoyama, Motonori Kimura, Shogo Fukuda, Shoji Seyama, Osamu Iketani, Yoshifumi Uwamino, Aya Jibiki, Hitoshi Kawazoe, Hisakazu Ohtani, Naoki Hasegawa, Kazuaki Matsumoto und 4 weitere

Biological and Pharmaceutical Bulletin · 2025

DOI: 10.1248/bpb.b24-00834 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Biological and Pharmaceutical Bulletin, 2025. Verfasst von Takaya Namiki und 15 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pharmaceutical Care Sciences, Keio University Graduate School of Pharmaceutical Sciences, 1-5-30 Shibakoen, Minato-ku, Tokyo 105-8512, Ja…. Hauptthemen laut MEDLINE: Urinary Tract Infections, Anti-Bacterial Agents, Escherichia coli, Cefmetazole. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Urinary Tract InfectionsAnti-Bacterial AgentsEscherichia coliCefmetazoleBacteremiaEscherichia coli InfectionsHumansMaleFemaleRetrospective StudiesAgedMiddle AgedMicrobial Sensitivity Testsbeta-LactamasesAged, 80 and overTreatment OutcomeAdult

Stichwörter der Autor:innen

antimicrobial stewardshipbacteremic urinary tract infectioncefmetazoleeffectivenessextended-spectrum β-lactamase producing enterobacterales

Substanzen

Anti-Bacterial AgentsCefmetazolebeta-Lactamases

Autor:innen und Institutionen

  • Division of Pharmaceutical Care Sciences, Keio University Graduate School of Pharmaceutical Sciences, 1-5-30 Shibakoen, Minato-ku, Tokyo 105-8512, Japan.
  • Department of Pharmacy, Tokyo Bay Urayasu Ichikawa Medical Center, 3-4-32 Todaijima, Urayasu, Chiba 279-0001, Japan.
  • Division of Pharmaceutical Care Sciences, Center for Social Pharmacy and Pharmaceutical Care Sciences, Keio University Faculty of Pharmacy, 1-5-30 Shibakoen, Minato-ku, Tokyo 105-8512, Japan.
  • Department of Pharmacy, Keio University Hospital, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan.
  • Division of Infectious Diseases and Infection Control, Keio University Hospital, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan.
  • Department of Clinical Microbiology, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences, 1432-1 Horinouchi, Hachioji, Tokyo 192-0392, Japan.

Zitieren

APA

Namiki, T., Yokoyama, Y., Kimura, M., Fukuda, S., Seyama, S., Iketani, O., Uwamino, Y., Jibiki, A., Kawazoe, H., Ohtani, H., Hasegawa, N., Matsumoto, K., Oda, R., Hashi, H., Suzuki, S., & Nakamura, T. (2025). Efficacy of De-Escalation to Cefmetazole in Patients with Bacteremic Urinary Tract Infections Caused by Extended-Spectrum β-Lactamase-Producing Escherichia coli. Biological and Pharmaceutical Bulletin. https://doi.org/10.1248/bpb.b24-00834

Vancouver

Namiki T, Yokoyama Y, Kimura M, Fukuda S, Seyama S, Iketani O, et al. Efficacy of De-Escalation to Cefmetazole in Patients with Bacteremic Urinary Tract Infections Caused by Extended-Spectrum β-Lactamase-Producing Escherichia coli. Biological and Pharmaceutical Bulletin. 2025. doi:10.1248/bpb.b24-00834

BibTeX
@article{Namiki2025,
  author = {Namiki, Takaya and Yokoyama, Yuta and Kimura, Motonori and Fukuda, Shogo and Seyama, Shoji and Iketani, Osamu and Uwamino, Yoshifumi and Jibiki, Aya and Kawazoe, Hitoshi and Ohtani, Hisakazu and Hasegawa, Naoki and Matsumoto, Kazuaki and Oda, Rentaro and Hashi, Hideki and Suzuki, Sayo and Nakamura, Tomonori},
  title = {Efficacy of De-Escalation to Cefmetazole in Patients with Bacteremic Urinary Tract Infections Caused by Extended-Spectrum β-Lactamase-Producing Escherichia coli},
  journal = {Biological and Pharmaceutical Bulletin},
  year = {2025},
  doi = {10.1248/bpb.b24-00834}
}
Kostenlos starten →